Daily Market Updates: Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

S&P 5007,592.40▼0.3% Nasdaq25,366.09▼0.4% Dow52,297.09▼0.4% Russell 2K2,799.06▼1.7% 10-Yr5.10%+10bp VIX18.70+1.21 WTI$88.74▲2.5% Gold$3,885.30▼2.9% EUR/USD1.109▼0.7% BTC$71,343▼3.5% Nikkei60,819▼0.7%

At close · Thu, Nov 12, 2026

ETFs & Funds

Home›ETFs & Funds›Equity Funds›Prediction markets tied to clinical trials and drug ap…

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Reported · CNBC Finance source summary · Equity Funds

Sens. Angela Alsobrooks and Ron Wyden are asking what steps the Department of Health and Human Services has taken to mitigate risks from the markets.

← Newer storyCould the Voter Backlash Against A.I. Actually Help the Economy?Older story →CoreWeave Finds a Workaround to Capital Constraints,for Now

More like this

ETFs & FundsBudget airlines are going upscale with first-class seats and faster wifi

ETFs & FundsNVDA, the CapEx Cycle & the 2027 AI Outlook

ETFs & FundsMedicare at age 50? What ‘Medicare for more’ could mean for American workers.

ETFs & FundsPosition for a Resilient Tech Sector With FTEC

ETFs & FundsNVDA Earnings: What Active ETFs Can Do

Sources

CNBC FinancePrediction markets tied to clinical trials and drug approvals draw lawmakers' ire

CNBC FinancePrediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.